866-997-4948(US-Canada Toll Free)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia

Published By :

GlobalData

Published Date : Sep 2017

Category :

Healthcare

No. of Pages : 215 Pages

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Russia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

In 2016, Russia population was approximately at 146.9 million. The government of Russia has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the countrys future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. Russias pharmaceutical market is one of the fastest growing in the world, and the largest in Central and Eastern Europe. Its value was RUB1.12 trillion in 2015 and increased at an Annual Growth Rate (AGR) of 7.8% in terms of rubles to RUB1.21 trillion in 2016. The market is expected to reach RUB2.22 trillion in 2021 at a CAGR of 12.9%. Based on the 2016 currency exchange rate of RUB1 to $0.0165, the market is expected to reach $36.61 billion by 2021. The Russian medical device market was valued at $5.0 billion in 2009 and is one of the most stable industries in the healthcare sector, due to the aging population and consequent increase in demand for healthcare products and services. It grew to $6.7 billion at a CAGR of 4.2% between 2009 and 2016 and is forecast to reach $8.5 billion in 2021. The segments expected to experience high growth are ophthalmic devices, wound care management, CVD, orthopedic devices and diagnostic imaging.

These positive trends can primarily be attributed to -
- An increasing elderly population in Russia, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices
- Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Russia, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Sanofi, Bayer, Roche and Pharmstandard)
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Russian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Russian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Russian healthcare market.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Executive Summary 9
3 Introduction 14
3.1 GlobalData Report Guidance 14
4 Overview of the Pharmaceutical and Medical Device Markets 15
4.1 Pharmaceutical Market 15
4.1.1 Market Overview 15
4.1.2 Pharmaceutical Exports and Imports 19
4.1.3 Supply Channels 20
4.1.4 Market Segments 22
4.1.5 Overview of Top Five Disease Areas 23
4.1.6 Major Players 25
4.2 Medical Device Market 56
4.2.1 Market Overview 56
4.2.2 Overview of Top Five Segments 58
4.2.3 Major Players 69
4.3 Market Drivers and Barriers 98
4.3.1 Drivers 98
4.3.2 Barriers 99
5 Market Access 102
5.1 Reimbursement and Payer Landscape 102
5.1.1 Overview of Healthcare System 102
5.1.2 Reimbursement Process 103
5.1.3 Overview of Insurance Providers 107
5.1.4 Patient Share in Healthcare Spending 108
5.1.5 Price Trend in Healthcare Services 109
5.1.6 Pricing Policies 110
5.2 Regulatory Landscape 112
5.2.1 Overview of Regulatory Agencies 112
5.2.2 Market Authorization Procedure for Pharmaceutical Products 114
5.2.3 Market Authorization Procedure for Medical Devices 120
5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 122
5.2.5 Licensing Process for Pharmaceutical Exports and Imports 123
5.2.6 Intellectual Property Rights 124
5.2.7 Clinical Trial Regulations 125
5.2.8 Pharmaceutical Advertising Regulations 126
5.2.9 Labeling and Packaging Regulations 127
6 Country Analysis 129
6.1 Political Environment 129
6.1.1 Political Structure 129
6.1.2 Analysis of the Current Political Environment 130
6.1.3 Healthcare Policy Initiatives 132
6.2 Economic Landscape 134
6.3 Economic Indicators 137
6.3.1 Gross Domestic Product 137
6.3.2 Gross National Income 142
6.3.3 Inflation 143
6.3.4 Currency Exchange Rate 145
6.3.5 Foreign Direct Investment 146
6.3.6 Foreign Exchange Reserves 147
6.3.7 Trade Balance 148
6.3.8 General Government Structural Balance 150
6.3.9 General Government Gross Debt 151
6.3.10 Major Industries 152
6.4 Demographics 153
6.4.1 Population 153
6.4.2 Education and Literacy 170
6.4.3 Employment 172
6.4.4 Disease Burden 174
6.5 Healthcare Infrastructure 176
6.5.1 Healthcare Facilities 176
6.5.2 Healthcare Parameters 181
6.5.3 Environmental Health 184
6.5.4 Healthcare Personnel 186
6.6 Healthcare Expenditure 187
6.6.1 Overview 187
6.6.2 Public-Private Sector Share 188
6.6.3 Major Components of Healthcare Spending 189
6.6.4 Spending in Science and Technology Research and Development 189
6.7 Trade Associations 190
6.7.1 Association of Russian Pharmaceutical Manufacturers 190
6.7.2 Association of International Pharmaceutical Manufacturers 190
6.7.3 Russian Association of Pharmaceutical Marketing 190
6.8 Trade Fairs 191
7 Opportunities and Challenges 192
7.1 Opportunities 192
7.2 Challenges 192
8 Appendix 195
8.1 Abbreviations 195
8.2 Bibliography 197
8.3 Research Methodology 213
8.3.1 Coverage 213
8.3.2 Secondary Research 213
8.3.3 Forecasts 214
8.3.4 Expert Panel 214
8.4 Contact Us 214
8.5 Disclaimer 215

1.1 List of Tables
Table 1: Pharmaceutical Market, Russia, Revenue ($bn), 2009-2016 19
Table 2: Pharmaceutical Market, Russia, Revenue Forecast ($bn), 2017-2021 19
Table 3: Pharmaceutical Market, Russia, Pharmaceutical Exports and Imports ($bn), 2009-2016 20
Table 4: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016 26
Table 5: Pharmaceutical Market, Novartis, Planned Filings, 2017-2021 27
Table 6: Sanofi, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016 35
Table 7: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2016 35
Table 8: Bayer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016 41
Table 9: Pharmaceutical Market,Roche, Global, Revenue ($m) and Annual Growth (%) of Major Products, 2016 47
Table 10: Pharmaceutical Market, Roche, Global, Late-stage Pipeline, 2017 48
Table 11: Medical Device Market, Russia, Revenue ($bn), 2009-2016 56
Table 12: Medical Device Market, Russia, Revenue Forecast ($bn), 2017-2021 57
Table 13: Medical Device Market, Russia, Revenue by Segment ($m), 2016 58
Table 14: Ophthalmic Devices Market, Russia, Revenue ($m), 2009-2016 59
Table 15: Ophthalmic Devices Market, Russia,Revenue ($m) and Market Share (%) of Major Companies, 2015 60
Table 16: Wound Care Management Market, Russia, Revenue ($m), 2009-2016 61
Table 17: Wound Care Management Market, Russia,Revenue ($m) and Market Share (%) of Major Companies, 2012 62
Table 18: Cardiovascular Devices Market, Russia, Revenue ($m), 2009-2016 63
Table 19: Cardiovascular Devices Market, Russia,Revenue ($m) and Market Share (%) of Major Companies, 2015 64
Table 20: Orthopedic Devices Market, Russia, Revenue of Major Players ($m), 2009-2016 65
Table 21: Orthopedic Devices Market, Russia,Revenue ($m) and Market Share (%) of Major Companies, 2015 66
Table 22: Diagnostic Imaging Market, Russia, Revenue ($m), 2009-2016 67
Table 23: Diagnostic Imaging Market, Russia,Revenue ($m) and Market Share (%) of Major Companies, 2015 68
Table 24: Medical Device Market, Russia, Revenue ($m) and Market Share (%) of Major Companies, 2015 69
Table 25: Medical Device Market,Medtronic, Major Products, 2016 76
Table 26: Baxter International, Global, Major Products, 2016 82
Table 27: Roche, Global,Major Products, 2015 87
Table 28: Medical Device Market, Roche, Global, Late-Stage Pipeline, 2016 88
Table 29: Healthcare Spending, Russia, Out-of-Pocket Expenditure (%), 2009-2015 109
Table 30: Medical Equipment Classification, Russia, 2016 121
Table 31: Medical Equipment Classification Based on Level of Risk, 2016 121
Table 32: Economic Indicators, Russia, Gross Domestic Product per Capita ($), 2009-2016 138
Table 33: Economic Indicators, Russia, Gross Domestic Product per Capita Forecast ($), 2017-2021 139
Table 34: Economic Indicators, Russia, Gross Domestic Product Annual Growth (%), 2009-2016 140
Table 35: Economic Indicators, Russia, Gross Domestic Product Annual Growth Forecast (%), 2017-2021 141
Table 36: Economic Indicators, Russia, Gross National Income per Capita ($), 2009-2016 142
Table 37: Economic Indicators, Russia, Average Consumer Price Index, 2009-2016 143
Table 38: Economic Indicators, Russia, Average Consumer Price Annual Change (%), 2009-2016 144
Table 39: Economic Indicators, Russia, Currency Exchange Rate (RUB per $), 2009-2016 145
Table 40: Economic Indicators, Russia, Foreign Direct Investment ($bn), 2009-2016 146
Table 41: Economic Indicators, Russia, Foreign Exchange Reserves ($bn), 2009-2016 147
Table 42: Economic Indicators, Russia, Imports of Goods and Services ($bn), 2009-2015 148
Table 43: Economic Indicators, Russia, Exports of Goods and Services ($bn), 2009-2015 149
Table 44: Economic Indicators, Russia, Government Structural Balance ($bn), 2009-2016 150
Table 45: Economic Indicators, Russia, General Government Gross Debt as a Percentage of GDP (%), 2009-2016 151
Table 46: Economic Indicators, Russia, Major Industries by Revenue Share (%), 2015 152
Table 47: Demographics, Russia, Population (million) , 2009-2021 154
Table 48: Demographics, Russia, Fertility rate (children/woman), 1989-2010 156
Table 49: Demographics, Russia, Urban-Rural Population Share (%), 2009-2016 157
Table 50: Demographics, Russia, Urban-Rural Population Share Forecast (%), 2017-2021 158
Table 51: Demographics, Russia, Population Distribution by Age Group (%), 2009-2016 159
Table 52: Demographics, Russia, Population Distribution by Age Group Forecast (%), 2017-2021 160
Table 53: Demographics, Russia, Births (per 1,000 population), 2009-2016 161
Table 54: Demographics, Russia, Mortality (per 1,000 population), 2009-2016 162
Table 55: Demographics, Russia, Major Causes of Mortality, 2015 163
Table 56: Demographics, Russia, Infant Mortality (per 1,000 live births), 2009-2016 164
Table 57: Demographics, Russia, Immunization Rate (%), 2009-2016 165
Table 58: Demographics, Russia, Major Causes of Male Mortality (per 100,000 population), 2015 167
Table 59: Demographics, Russia, Major Causes of Female Mortality (per 100,000 population), 2015 168
Table 60: Demographics, Russia, Gender Ratio (M/F), 2009-2015 169
Table 61: Demographics, Russia, Life Expectancy at Birth (years), 2009-2016 169
Table 62: Demographics, Russia, Enrolment by Level of Education (000), 2009-2015 171
Table 63: Demographics, Russia, Unemployment Rate (%), 2009-2015 172
Table 64: Demographics, Russia, Distribution of Employment by Industry(%), 2015 173
Table 65: Demographics, Russia, Morbidity (000), 2015 174
Table 66: Demographics, Russia, Disability-Adjusted Life Years by Major Disease (000), 2012 176
Table 67: Healthcare Infrastructure, Russia, Number of Hospitals (000), 2009-2015 177
Table 68: Healthcare Infrastructure, Russia, Number of Outpatient Clinics (000), 2009-2015 177
Table 69: Healthcare Infrastructure, Russia, Public and Private Hospitals, 2009-2015 178
Table 70: Healthcare Infrastructure, Russia, Hospital Beds by Specialization (000), 2014 179
Table 71: Healthcare Infrastructure, Russia, Diagnostic Equipment (per million population), 2009-2015 180
Table 72: Healthcare Infrastructure, Russia, Hospital Beds (per 10,000 population), 2009-2015 181
Table 73: Healthcare Infrastructure, Russia, Doctors (per 10,000 population), 2009-2015 182
Table 74: Healthcare Infrastructure, Russia, Doctors by Specialization (000), 2014 183
Table 75: Healthcare Infrastructure, Russia, PM2.5 (g per m3), 2009-2015 184
Table 76: Healthcare Infrastructure, Russia, CO2 Emissions (million metric tons), 2009-2015 185
Table 77: Healthcare Infrastructure, Russia, Healthcare Personnel (000), 2014 186
Table 78: Healthcare Expenditure, Russia, Healthcare Expenditure as a Percentage of GDP (%), 2009-2015 187
Table 79: Healthcare Expenditure, Russia, Public-Private Share (%), 2009-2015 188
Table 80: Healthcare Expenditure, Russia, R&D Expenditure as a Percentage of GDP (%), 2009-2015 189
Table 81: Healthcare Expenditure, Russia, Major Healthcare Trade Fairs, 2017 191

1.2 List of Figures
Figure 1: Pharmaceutical Market, Russia, Revenue ($bn), 2009-2021 10
Figure 2: Medical Device Market, Russia, Revenue ($bn), 2009-2021 11
Figure 3: Country Profile, Russia, 2017 13
Figure 4: Pharmaceutical Market, Russia, Revenue ($bn), 2009-2016 18
Figure 5: Pharmaceutical Market, Russia, Revenue Forecast ($bn), 2017-2021 19
Figure 6: Pharmaceutical Market, Russia, Pharmaceutical Exports and Imports ($bn), 2009-2016 20
Figure 7: Medical Device Market, Russia, Revenue ($bn), 2009-2016 56
Figure 8: Medical Device Market, Russia, Revenue Forecast ($bn), 2017-2021 57
Figure 9: Medical Device Market, Russia, Revenue by Segment ($m), 2016 58
Figure 10: Ophthalmic Devices Market, Russia, Revenue ($m), 2009-2016 59
Figure 11: Ophthalmic Devices Market, Russia, Market Share of Major Players (%), 2015 60
Figure 12: Wound Care Management Market, Russia, Revenue ($m), 2009-2016 61
Figure 13: Wound Care Management Market, Russia, Market Share of Major Players (%), 2012 62
Figure 14: Cardiovascular Devices Market, Russia, Revenue ($m), 2009-2016 63
Figure 15: Cardiovascular Devices Market, Russia, Market Share of Major Players (%), 2015 64
Figure 16: Orthopedic Devices Market, Russia, Revenue ($m), 2009-2016 65
Figure 17: Orthopedic Devices Market, Russia, Market Share of Major Players (%), 2015 66
Figure 18: Diagnostic Imaging Market, Russia, Revenue ($m), 2009-2016 67
Figure 19: Diagnostic Imaging Market, Russia, Market Share of Major Companies (%), 2015 68
Figure 20: Medical Device Market, Russia, Revenue of Major Companies ($m), 2015 69
Figure 21: Healthcare Market, Russia, Drivers and Barriers, 2017 101
Figure 22: Market Access, Russia, Procedure for Inclusion of Drugs in Reimbursement Lists, 2017 106
Figure 23: Healthcare Spending, Russia, Out-of-Pocket Expenditure (%), 2009-2015 109
Figure 24: Market Access, Russia, Step-down Approach for Generics and Biosimilars Price Calculation, 2017 112
Figure 25: Market Access, Russia, Overview of Medicines Market Regulation, 2017 114
Figure 26: Market Access, Russia, Drug Registration Procedure, 2017 116
Figure 27: Market Access, Russia, Drug Registration Procedure based on Clinical Trials, 2017 116
Figure 28: Market Access, Russia, GMP Inspection Procedure, 2017 119
Figure 29: Economic Indicators, Russia, Gross Domestic Product Per Capita ($), 2009-2016 138
Figure 30: Economic Indicators, Russia, Gross Domestic Product per Capita Forecast ($), 2017-2021 139
Figure 31: Economic Indicators, Russia, Gross Domestic Product Annual Growth (%), 2009-2016 140
Figure 32: Economic Indicators, Russia, Gross Domestic Product Annual Growth Forecast (%), 2017-2021 141
Figure 33: Economic Indicators, Russia, Gross National Income per Capita ($), 2009-2016 142
Figure 34: Economic Indicators, Russia, Average Consumer Price Index, 2009-2016 143
Figure 35: Economic Indicators, Russia, Average Consumer Price Annual Change (%), 2009-2016 144
Figure 36: Economic Indicators, Russia, Currency Exchange Rate ($/RUB) 2009-2016 145
Figure 37: Economic Indicators, Russia, Foreign Direct Investment ($bn), 2009-2016 146
Figure 38: Economic Indicators, Russia, Foreign Exchange Reserves ($bn), 2009-2016 147
Figure 39: Economic Indicators, Russia, Imports of Goods and Services ($bn), 2009-2015 148
Figure 40: Economic Indicators, Russia, Exports of Goods and Services ($bn), 2009-2015 149
Figure 41: Economic Indicators, Russia, Government Structural Balance ($bn), 2009-2016 150
Figure 42: Economic Indicators, Russia, General Government Gross Debt as a Percentage of GDP (%), 2009-2016 151
Figure 43: Economic Indicators, Russia, Major Industries by Revenue Share (%), 2015 152
Figure 44: Demographics, Russia, Population (million) , 2009-2021 154
Figure 45: Demographics, Russia, Fertility rate (children/woman), 1989-2010 155
Figure 46: Demographics, Russia, Urban-Rural Population Share (%), 2009-2016 157
Figure 47: Demographics, Russia, Urban-Rural Population Share Forecast (%), 2017-2021 158
Figure 48: Demographics, Russia, Population Distribution by Age Group (%), 2009-2016 159
Figure 49: Demographics, Russia, Population Distribution by Age Group Forecast (%), 2017-2021 160
Figure 50: Demographics, Russia, Births (per 1,000 population), 2009-2016 161
Figure 51: Demographics, Russia, Mortality (per 1,000 population), 2009-2016 162
Figure 52: Demographics, Russia, Major Causes of Mortality, 2015 163
Figure 53: Demographics, Russia, Infant Mortality (per 1,000 live births), 2009-2016 164
Figure 54: Demographics, Russia, Immunization Rate (%), 2009-2016 165
Figure 55: Demographics, Russia, Major Causes of Male Mortality (per 100,000 population), 2015 166
Figure 56: Demographics, Russia, Major Causes of Female Mortality (per 100,000 population), 2015 167
Figure 57: Demographics, Russia, Gender Ratio (M/F), 2009-2015 168
Figure 58: Demographics, Russia, Life Expectancy at Birth (years), 2009-2016 169
Figure 59: Demographics, Russia, Enrolment by Level of Education (000), 2009-2015 171
Figure 60: Demographics, Russia, Unemployment Rate (%), 2009-2015 172
Figure 61: Demographics, Russia, Distribution of Employment by Industry (%), 2015 173
Figure 62: Demographics, Russia, Morbidity (000), 2015 174
Figure 63: Demographics, Russia, Disability-Adjusted Life Years by Major Disease (000), 2012 175
Figure 64: Healthcare Infrastructure, Russia, Number of Hospitals (000), 2009-2015 176
Figure 65: Healthcare Infrastructure, Russia, Number of Outpatient Clinics (000), 2009-2015 177
Figure 66: Healthcare Infrastructure, Russia, Public and Private Hospitals, 2009-2015 178
Figure 67: Healthcare Infrastructure, Russia, Hospital Beds by Specialization (000), 2014 179
Figure 68: Healthcare Infrastructure, Russia, Diagnostic Equipment (per million population), 2009-2015 180
Figure 69: Healthcare Infrastructure, Russia, Hospital Beds (per 10,000 population), 2009-2015 181
Figure 70: Healthcare Infrastructure, Russia, Doctors (per 10,000 population), 2009-2015 182
Figure 71: Healthcare Infrastructure, Russia, Doctors by Specialization (000), 2014 183
Figure 72: Healthcare Infrastructure, Russia, PM2.5 (g per m3), 2009-2015 184
Figure 73: Healthcare Infrastructure, Russia, CO2 Emissions (million metric tons), 2009-2015 185
Figure 74: Healthcare Infrastructure, Russia, Healthcare Personnel (000), 2014 186
Figure 75: Healthcare Expenditure, Russia, Healthcare Expenditure as a Percentage of GDP (%), 2009-2015 187
Figure 76: Healthcare Expenditure, Russia, Public-Private Share (%), 2009-2015 188
Figure 77: Healthcare Expenditure, Russia, R&D Expenditure as a Percentage of GDP (%), 2009-2015 189
Figure 78: Healthcare Market, Russia, Opportunities and Challenges, 2017 194

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *